Evidence map›Paper›PMID 34795844›Full record

ArticleOxidative medicine and cellular longevity2021

Bisdemethoxycurcumin Protects Small Intestine from Lipopolysaccharide-Induced Mitochondrial Dysfunction via Activating Mitochondrial Antioxidant Systems and Mitochondrial Biogenesis in Broiler Chickens.

Jingfei Zhang, Yuxiang Yang, Hongli Han, Lili Zhang, Tian Wang

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 18 citations in OpenAlex.

  1. Effects ofBiology · 2025
    Article
  2. Antioxidant Effect of Ethyl Acetate Fraction fromAntioxidants (Basel, Switzerland) · 2025
    Article
  3. Article
  4. The benefits of ashwagandha (Frontiers in nutrition · 2024
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Antioxidants (Basel, Switzerland) · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Frontiers in cellular and infection microbiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Jingfei ZhangCollege of Animal Science and Technology, Nanjing Agricultural University, Nanjing 210095, China.ORCID https://orcid.org/0000-0002-6722-1524
Yuxiang YangBluestar Adisseo Nanjing Co., Ltd., Nanjing 210047, China.ORCID https://orcid.org/0000-0002-4833-8399
Hongli HanCollege of Animal Science and Technology, Nanjing Agricultural University, Nanjing 210095, China.ORCID https://orcid.org/0000-0001-5276-5652
Lili ZhangCollege of Animal Science and Technology, Nanjing Agricultural University, Nanjing 210095, China.ORCID https://orcid.org/0000-0002-4773-5157
Tian WangCollege of Animal Science and Technology, Nanjing Agricultural University, Nanjing 210095, China.ORCID https://orcid.org/0000-0002-9038-5009
Nanjing Agricultural University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bisdemethoxycurcumin is one of the three curcuminoids of turmeric and exhibits good antioxidant activity in animal models. This study is aimed at investigating the effect of bisdemethoxycurcumin on small intestinal mitochondrial dysfunction in lipopolysaccharide- (LPS-) treated broilers, especially on the mitochondrial thioredoxin 2 system and mitochondrial biogenesis. A total of 320 broiler chickens were randomly assigned into four experimental diets using a 2 × 2 factorial arrangement with diet (0 and 150 mg/kg bisdemethoxycurcumin supplementation) and stress (saline or LPS challenge) for 20 days. Broilers received a dose of LPS (1 mg/kg body weight) or sterile saline intraperitoneally on days 16, 18, and 20 of the trial. Bisdemethoxycurcumin mitigated the mitochondrial dysfunction of jejunum and ileum induced by LPS, as evident by the reduced reactive oxygen species levels and the increased mitochondrial membrane potential. Bisdemethoxycurcumin partially reversed the decrease in the mitochondrial DNA copy number and the depletion of ATP levels. Bisdemethoxycurcumin activated the mitochondrial antioxidant response, including the prevention of lipid peroxidation, enhancement of manganese superoxide dismutase activity, and the upregulation of the mitochondrial glutaredoxin 5 and thioredoxin 2 system. The enhanced mitochondrial respiratory complex activities in jejunum and ileum were also attributed to bisdemethoxycurcumin treatment. In addition, bisdemethoxycurcumin induced mitochondrial biogenesis via transcriptional regulation of proliferator-activated receptor-gamma coactivator-1alpha pathway. In conclusion, our results demonstrated the potential of bisdemethoxycurcumin to attenuate small intestinal mitochondrial dysfunction, which might be mediated via activating the mitochondrial antioxidant system and mitochondrial biogenesis in LPS-treated broilers.

Indexed as

AnimalsAntioxidantsChickensDiarylheptanoidsGene Expression RegulationInflammationIntestinal DiseasesIntestine, SmallLipopolysaccharidesMaleMitochondriaProtective AgentsReactive Oxygen SpeciesAntioxidantsbisdemethoxycurcuminDiarylheptanoidsLipopolysaccharidesProtective AgentsReactive Oxygen Species

Identifiers

PMID34795844
PMCPMC8595021
OpenAlexW3213336743

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.